Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Kamada Ltd.

Market Cap 1.26B 0 434M 374M 344M 323M 607M 41.01B 613M 4.07B 1.59B 20.08B 1.63B 1.59B 69.49B P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 1.26B 0 434M 374M 344M 323M 607M 41.01B 613M 4.07B 1.59B 20.08B 1.63B 1.59B 69.49B EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.96x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
1 day+0.28%
1 week+1.11%
Current month-1.49%
1 month-6.79%
3 months-20.46%
6 months-3.96%
Current year-3.50%
1 week 2,130
Extreme 2130
2,208
1 month 2,093
Extreme 2093
2,334
Current year 2,093
Extreme 2093
2,890
1 year 1,956
Extreme 1956
2,890
3 years 1,685
Extreme 1685
3,045
5 years 1,309
Extreme 1309
3,045
10 years 1,309
Extreme 1309
4,500
Manager TitleAgeSince
Chief Executive Officer 57 01/07/2015
Director of Finance/CFO 55 31/12/2017
Chief Operating Officer 53 01/11/2016
Director TitleAgeSince
Director/Board Member 75 13/12/1990
Chairman 77 07/03/2013
Chairman 55 12/08/2020
Date Insider Type Main position Quantity % Market Cap.
04-07Free

Director

32,000 0.0555%
04-07Free

Chief Executive Officer

1,600,000 2.7738%
04-07Free

Chief Financial Officer

405,000 0.7021%
Change 5-day change 1-year change 3-year change Capi.($)
+0.28%+1.11%-10.83%+11.56% 430M
+0.46%-3.22%+16.20%-20.25% 62.28B
-5.71%-0.69%+58.58%+208.79% 60.59B
+2.86%+33.20%+33.20%+33.20% 39.55B
-1.84%+7.78%-55.82%-63.26% 36.8B
-0.70%+1.69%+52.04%-33.78% 29.53B
-6.04%-0.39%+50.52%+65.98% 21.68B
+4.45%+9.89%+95.46%-58.64% 19.8B
+1.24%+1.04%-4.09%+126.32% 16.96B
-0.96%-2.60%+52.63%+93.85% 16.16B
Average -0.64%+2.68%+28.79%+36.38% 30.38B
Weighted average by Cap. -1.12%+2.76%+30.01%+43.81%

Financials

2026 *2027 *
Net sales 585M 0 202M 174M 160M 150M 282M 19.06B 285M 1.89B 739M 9.33B 757M 741M 32.3B 642M 0 221M 191M 176M 165M 309M 20.92B 313M 2.08B 811M 10.25B 831M 813M 35.45B
Net income 72.01M 0 24.84M 21.41M 19.7M 18.48M 34.72M 2.35B 35.06M 233M 90.98M 1.15B 93.21M 91.23M 3.98B 104M 0 35.75M 30.81M 28.36M 26.6M 49.97M 3.38B 50.47M 335M 131M 1.65B 134M 131M 5.72B
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
462
Date Price Change Volume
15/06/26 2,181.00 ILa +0.28% 39,654
12/06/26 2,175.00 ILa +0.74% 11,810
11/06/26 2,159.00 ILa +0.61% 45,595
10/06/26 2,146.00 ILa 0.00% 27,942
09/06/26 2,146.00 ILa -0.09% 24,910
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KMDA Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!